Connection

Andrew Kraft to Proto-Oncogene Proteins

This is a "connection" page, showing publications Andrew Kraft has written about Proto-Oncogene Proteins.
Connection Strength

2.850
  1. Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res. 2005 Aug; 3(8):443-51.
    View in: PubMed
    Score: 0.208
  2. Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix association. Mol Cancer Res. 2005 Jul; 3(7):391-401.
    View in: PubMed
    Score: 0.207
  3. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Mol Cancer Ther. 2005 Mar; 4(3):443-9.
    View in: PubMed
    Score: 0.202
  4. Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylation. J Biol Chem. 2004 Dec 17; 279(51):53116-25.
    View in: PubMed
    Score: 0.197
  5. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res. 2003 Jan-Feb; 23(1A):167-78.
    View in: PubMed
    Score: 0.174
  6. Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak/Stat signaling and differentiation. Blood. 2001 Mar 15; 97(6):1662-70.
    View in: PubMed
    Score: 0.154
  7. Bax-induced apoptotic cell death. Proc Natl Acad Sci U S A. 2000 Jan 18; 97(2):529-31.
    View in: PubMed
    Score: 0.142
  8. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene. 1999 Jul 08; 18(27):4022-31.
    View in: PubMed
    Score: 0.137
  9. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018 07 02; 128(7):2787-2801.
    View in: PubMed
    Score: 0.126
  10. Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. Cancer Res. 1997 Dec 01; 57(23):5348-55.
    View in: PubMed
    Score: 0.122
  11. Signal transduction by a CD16/CD7/Jak2 fusion protein. J Biol Chem. 1995 Aug 04; 270(31):18420-7.
    View in: PubMed
    Score: 0.104
  12. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem. 1995 Jun 16; 270(24):14776-85.
    View in: PubMed
    Score: 0.103
  13. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain. J Biol Chem. 1995 Jun 09; 270(23):13814-8.
    View in: PubMed
    Score: 0.103
  14. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets. Oncotarget. 2014 Sep 30; 5(18):8503-14.
    View in: PubMed
    Score: 0.098
  15. Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice. J Hematol Oncol. 2013 Jan 29; 6:12.
    View in: PubMed
    Score: 0.087
  16. Regulation of c-jun expression and AP-1 enhancer activity by granulocyte-macrophage colony-stimulating factor. J Biol Chem. 1991 Mar 25; 266(9):5670-5.
    View in: PubMed
    Score: 0.077
  17. The BH3 mimetic ABT-737 induces cancer cell senescence. Cancer Res. 2011 Jan 15; 71(2):506-15.
    View in: PubMed
    Score: 0.075
  18. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase. Mol Cancer Res. 2010 Aug; 8(8):1126-41.
    View in: PubMed
    Score: 0.073
  19. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood. 2010 Jan 28; 115(4):824-33.
    View in: PubMed
    Score: 0.070
  20. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60). Oncogene. 1987 May; 1(2):111-8.
    View in: PubMed
    Score: 0.059
  21. Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Cancer Res. 2003 Dec 01; 63(23):8079-84.
    View in: PubMed
    Score: 0.046
  22. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem. 2003 Nov 14; 278(46):45358-67.
    View in: PubMed
    Score: 0.046
  23. The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. Oncogene. 2003 Aug 07; 22(32):4953-63.
    View in: PubMed
    Score: 0.045
  24. The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation. J Biol Chem. 1997 Jul 11; 272(28):17450-9.
    View in: PubMed
    Score: 0.030
  25. The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells. J Biol Chem. 1997 May 09; 272(19):12350-8.
    View in: PubMed
    Score: 0.029
  26. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol Endocrinol. 1996 Nov; 10(11):1425-43.
    View in: PubMed
    Score: 0.028
  27. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology. 1994 Nov; 135(5):2228-39.
    View in: PubMed
    Score: 0.025
  28. A critical role for the cytoplasmic domain of the granulocyte-macrophage colony-stimulating factor alpha receptor in mediating cell growth. Cell Growth Differ. 1993 Jun; 4(6):523-31.
    View in: PubMed
    Score: 0.022
  29. Multiple signal transduction pathways mediate c-Jun protein phosphorylation. Cell Growth Differ. 1993 May; 4(5):377-85.
    View in: PubMed
    Score: 0.022
  30. Multiple doses of diacylglycerol and calcium ionophore are necessary to activate AP-1 enhancer activity and induce markers of macrophage differentiation. J Biol Chem. 1990 Oct 25; 265(30):18166-71.
    View in: PubMed
    Score: 0.019
  31. Induction of the proto-oncogene c-jun by angiotensin II. Mol Cell Biol. 1990 Oct; 10(10):5536-40.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.